Copyright
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Feb 26, 2016; 8(2): 114-119
Published online Feb 26, 2016. doi: 10.4330/wjc.v8.i2.114
Published online Feb 26, 2016. doi: 10.4330/wjc.v8.i2.114
Omega 3 and atrial fibrillation: Where are we?
Annamaria Martino, Leonardo Calo’, Division of Cardiology, Policlinico Casilino, 00169 Rome, Italy
Annamaria Martino, Department of Cardiovascular, Respiratory, Nephrologic and Geriatrics Sciences, Umberto I Hospital, Sapienza University, 00100 Rome, Italy
Laura Pezzi, Roberta Magnano, Elisa Salustri, Maria Penco, Department of Cardiology, University of l’Aquila, 67100 L’Aquila, Italy
Author contributions: Martino A and Calo’ L designed the research; Pezzi L, Magnano R and Salustri E performed the research; Martino A, Pezzi L, Magnano R and Salustri E analyzed the data; Martino A, Pezzi L, Magnano R, Salustri E, Penco M and Calo’ L wrote the paper.
Conflict-of-interest statement: The authors declare no conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Leonardo Calo’, MD, FESC, Division of Cardiology, Policlinico Casilino, ASL Rome B, 00169 Rome, Italy. leonardo.calo@tin.it
Telephone: +39-06-23188416 Fax: +39-06-23188410
Received: June 3, 2015
Peer-review started: June 3, 2015
First decision: September 26, 2015
Revised: November 24, 2015
Accepted: December 29, 2015
Article in press: January 4, 2016
Published online: February 26, 2016
Peer-review started: June 3, 2015
First decision: September 26, 2015
Revised: November 24, 2015
Accepted: December 29, 2015
Article in press: January 4, 2016
Published online: February 26, 2016
Core Tip
Core tip: Individual variability in response to fish oil administration, in terms of eicosapentaenoic and docosahexaenoic acids in corporation into cell membranes, is responsible for controversial results of n-3 poly-unsaturated fatty acids administration in patients suffering atrial fibrillation.